From Transplant to Reamputation: A Case Report on Chronic Rejection and Innovative Treatment in Hand Allotransplantation
Elsaftawy A., Jagosz M., Smorąg M., Węgrzyn P., Kamińska D., Bonczar M.
Prospective Study, published in Plast Reconstr Surg Glob Open (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Prospective Study
- Journal
- Plast Reconstr Surg Glob Open (2025)
- Reported sample size
- —
- Source database
- Europe PMC
- PMID
- 40496989
- PMCID
- PMC12150955
- DOI
- 10.1097/gox.0000000000006893
Abstract (original English)
Vascularized composite allotransplantation provides upper limb amputation patients with functional and aesthetic restoration but is limited by the challenges of chronic rejection. This case report highlights a patient who underwent right-hand transplantation and experienced repeated rejection episodes, chronic pain, and functional decline. Despite standard immunosuppressive regimens and innovative interventions such as fat grafting with platelet-rich plasma, chronic rejection symptoms persisted. Fat grafting demonstrated short-term improvements in skin texture and inflammation but failed to prevent progressive deterioration. Ultimately, the patient opted for reamputation, prioritizing quality of life over the prolonged burden of managing a failing graft. This case showcases the complexities of managing chronic rejection in vascularized composite allotransplantation and highlights the need for individualized, patient-centered approaches that respect autonomy and prioritize overall well-being.
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.